0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Powder Inhalation Excipients Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-38H18504
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dry Powder Inhalation Excipients Market Research Report 2024
BUY CHAPTERS

Global Dry Powder Inhalation Excipients Market Research Report 2026

Code: QYRE-Auto-38H18504
Report
2026-01-21
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Powder Inhalation Excipients Market Size

The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.

Dry Powder Inhalation Excipients Market

Dry Powder Inhalation Excipients Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dry Powder Inhalation Excipients competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.
The North American market for Dry Powder Inhalation Excipients is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Dry Powder Inhalation Excipients is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Dry Powder Inhalation Excipients include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Dry Powder Inhalation Excipients market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dry Powder Inhalation Excipients. The Dry Powder Inhalation Excipients market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dry Powder Inhalation Excipients market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dry Powder Inhalation Excipients manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Dry Powder Inhalation Excipients Market Report

Report Metric Details
Report Name Dry Powder Inhalation Excipients Market
Accounted market size in 2025 US$ 1817 million
Forecasted market size in 2032 US$ 2613 million
CAGR 5.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Lactose
  • Magnesium Stearate
  • Others
by Application
  • DPI
  • MDI
  • Nebulizer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, Jiangsu Daoning Drug
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Dry Powder Inhalation Excipients manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Dry Powder Inhalation Excipients sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Dry Powder Inhalation Excipients Market growing?

Ans: The Dry Powder Inhalation Excipients Market witnessing a CAGR of 5.4% during the forecast period 2026-2032.

What is the Dry Powder Inhalation Excipients Market size in 2032?

Ans: The Dry Powder Inhalation Excipients Market size in 2032 will be US$ 2613 million.

Who are the main players in the Dry Powder Inhalation Excipients Market report?

Ans: The main players in the Dry Powder Inhalation Excipients Market are Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, Jiangsu Daoning Drug

What are the Application segmentation covered in the Dry Powder Inhalation Excipients Market report?

Ans: The Applications covered in the Dry Powder Inhalation Excipients Market report are DPI, MDI, Nebulizer, Others

What are the Type segmentation covered in the Dry Powder Inhalation Excipients Market report?

Ans: The Types covered in the Dry Powder Inhalation Excipients Market report are Lactose, Magnesium Stearate, Others

1 Dry Powder Inhalation Excipients Market Overview
1.1 Product Definition
1.2 Dry Powder Inhalation Excipients by Type
1.2.1 Global Dry Powder Inhalation Excipients Market Value by Type: 2025 vs 2032
1.2.2 Lactose
1.2.3 Magnesium Stearate
1.2.4 Others
1.3 Dry Powder Inhalation Excipients by Application
1.3.1 Global Dry Powder Inhalation Excipients Market Value by Application: 2025 vs 2032
1.3.2 DPI
1.3.3 MDI
1.3.4 Nebulizer
1.3.5 Others
1.4 Global Dry Powder Inhalation Excipients Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhalation Excipients Revenue 2021–2032
1.4.2 Global Dry Powder Inhalation Excipients Sales 2021–2032
1.4.3 Global Dry Powder Inhalation Excipients Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dry Powder Inhalation Excipients Market Competition by Manufacturers
2.1 Global Dry Powder Inhalation Excipients Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dry Powder Inhalation Excipients Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dry Powder Inhalation Excipients Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dry Powder Inhalation Excipients, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dry Powder Inhalation Excipients, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhalation Excipients, Product Types and Applications
2.7 Global Key Manufacturers of Dry Powder Inhalation Excipients, Date of Entry into the Industry
2.8 Global Dry Powder Inhalation Excipients Market Competitive Situation and Trends
2.8.1 Global Dry Powder Inhalation Excipients Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dry Powder Inhalation Excipients Players Market Share by Revenue
2.8.3 Global Dry Powder Inhalation Excipients Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dry Powder Inhalation Excipients Market Scenario by Region
3.1 Global Dry Powder Inhalation Excipients Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dry Powder Inhalation Excipients Sales by Region: 2021–2032
3.2.1 Global Dry Powder Inhalation Excipients Sales by Region: 2021–2026
3.2.2 Global Dry Powder Inhalation Excipients Sales by Region: 2027–2032
3.3 Global Dry Powder Inhalation Excipients Revenue by Region: 2021–2032
3.3.1 Global Dry Powder Inhalation Excipients Revenue by Region: 2021–2026
3.3.2 Global Dry Powder Inhalation Excipients Revenue by Region: 2027–2032
3.4 North America Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.4.3 North America Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.5.3 Europe Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Powder Inhalation Excipients Market Facts & Figures by Region
3.6.1 Asia Pacific Dry Powder Inhalation Excipients Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dry Powder Inhalation Excipients Sales by Region (2021–2032)
3.6.3 Asia Pacific Dry Powder Inhalation Excipients Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.7.3 Latin America Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Powder Inhalation Excipients Sales by Type (2021–2032)
4.1.1 Global Dry Powder Inhalation Excipients Sales by Type (2021–2026)
4.1.2 Global Dry Powder Inhalation Excipients Sales by Type (2027–2032)
4.1.3 Global Dry Powder Inhalation Excipients Sales Market Share by Type (2021–2032)
4.2 Global Dry Powder Inhalation Excipients Revenue by Type (2021–2032)
4.2.1 Global Dry Powder Inhalation Excipients Revenue by Type (2021–2026)
4.2.2 Global Dry Powder Inhalation Excipients Revenue by Type (2027–2032)
4.2.3 Global Dry Powder Inhalation Excipients Revenue Market Share by Type (2021–2032)
4.3 Global Dry Powder Inhalation Excipients Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dry Powder Inhalation Excipients Sales by Application (2021–2032)
5.1.1 Global Dry Powder Inhalation Excipients Sales by Application (2021–2026)
5.1.2 Global Dry Powder Inhalation Excipients Sales by Application (2027–2032)
5.1.3 Global Dry Powder Inhalation Excipients Sales Market Share by Application (2021–2032)
5.2 Global Dry Powder Inhalation Excipients Revenue by Application (2021–2032)
5.2.1 Global Dry Powder Inhalation Excipients Revenue by Application (2021–2026)
5.2.2 Global Dry Powder Inhalation Excipients Revenue by Application (2027–2032)
5.2.3 Global Dry Powder Inhalation Excipients Revenue Market Share by Application (2021–2032)
5.3 Global Dry Powder Inhalation Excipients Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Protheragen-ING
6.1.1 Protheragen-ING Company Information
6.1.2 Protheragen-ING Description and Business Overview
6.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Protheragen-ING Dry Powder Inhalation Excipients Product Portfolio
6.1.5 Protheragen-ING Recent Developments/Updates
6.2 DFE Pharma
6.2.1 DFE Pharma Company Information
6.2.2 DFE Pharma Description and Business Overview
6.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 DFE Pharma Dry Powder Inhalation Excipients Product Portfolio
6.2.5 DFE Pharma Recent Developments/Updates
6.3 Meggle-Pharma
6.3.1 Meggle-Pharma Company Information
6.3.2 Meggle-Pharma Description and Business Overview
6.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Product Portfolio
6.3.5 Meggle-Pharma Recent Developments/Updates
6.4 Pfanstiehl
6.4.1 Pfanstiehl Company Information
6.4.2 Pfanstiehl Description and Business Overview
6.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Pfanstiehl Dry Powder Inhalation Excipients Product Portfolio
6.4.5 Pfanstiehl Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Merck Dry Powder Inhalation Excipients Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Sheffield (Kerry)
6.6.1 Sheffield (Kerry) Company Information
6.6.2 Sheffield (Kerry) Description and Business Overview
6.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Product Portfolio
6.6.5 Sheffield (Kerry) Recent Developments/Updates
6.7 Armor Pharma
6.7.1 Armor Pharma Company Information
6.7.2 Armor Pharma Description and Business Overview
6.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Armor Pharma Dry Powder Inhalation Excipients Product Portfolio
6.7.5 Armor Pharma Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abbott Dry Powder Inhalation Excipients Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Norvatis
6.9.1 Norvatis Company Information
6.9.2 Norvatis Description and Business Overview
6.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Norvatis Dry Powder Inhalation Excipients Product Portfolio
6.9.5 Norvatis Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Company Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bayer Dry Powder Inhalation Excipients Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Jiangsu Daoning Drug
6.11.1 Jiangsu Daoning Drug Company Information
6.11.2 Jiangsu Daoning Drug Description and Business Overview
6.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Portfolio
6.11.5 Jiangsu Daoning Drug Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhalation Excipients Industry Chain Analysis
7.2 Dry Powder Inhalation Excipients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhalation Excipients Production Mode & Process Analysis
7.4 Dry Powder Inhalation Excipients Sales and Marketing
7.4.1 Dry Powder Inhalation Excipients Sales Channels
7.4.2 Dry Powder Inhalation Excipients Distributors
7.5 Dry Powder Inhalation Excipients Customer Analysis
8 Dry Powder Inhalation Excipients Market Dynamics
8.1 Dry Powder Inhalation Excipients Industry Trends
8.2 Dry Powder Inhalation Excipients Market Drivers
8.3 Dry Powder Inhalation Excipients Market Challenges
8.4 Dry Powder Inhalation Excipients Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Dry Powder Inhalation Excipients Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Dry Powder Inhalation Excipients Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Dry Powder Inhalation Excipients Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Dry Powder Inhalation Excipients Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Dry Powder Inhalation Excipients Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Dry Powder Inhalation Excipients Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Dry Powder Inhalation Excipients Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Dry Powder Inhalation Excipients Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Dry Powder Inhalation Excipients, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Dry Powder Inhalation Excipients, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Dry Powder Inhalation Excipients, Product Types and Applications
 Table 12. Global Key Manufacturers of Dry Powder Inhalation Excipients, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dry Powder Inhalation Excipients Companies by Tier (Tier 1, Tier 2, Tier 3), based on Dry Powder Inhalation Excipients Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dry Powder Inhalation Excipients Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Dry Powder Inhalation Excipients Sales by Region (Tons), 2021–2026
 Table 18. Global Dry Powder Inhalation Excipients Sales Market Share by Region (2021–2026)
 Table 19. Global Dry Powder Inhalation Excipients Sales by Region (Tons), 2027–2032
 Table 20. Global Dry Powder Inhalation Excipients Sales Market Share by Region (2027–2032)
 Table 21. Global Dry Powder Inhalation Excipients Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Dry Powder Inhalation Excipients Revenue Market Share by Region (2021–2026)
 Table 23. Global Dry Powder Inhalation Excipients Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Dry Powder Inhalation Excipients Revenue Market Share by Region (2027–2032)
 Table 25. North America Dry Powder Inhalation Excipients Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Dry Powder Inhalation Excipients Sales by Country (Tons), 2021–2026
 Table 27. North America Dry Powder Inhalation Excipients Sales by Country (Tons), 2027–2032
 Table 28. North America Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Dry Powder Inhalation Excipients Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Dry Powder Inhalation Excipients Sales by Country (Tons), 2021–2026
 Table 32. Europe Dry Powder Inhalation Excipients Sales by Country (Tons), 2027–2032
 Table 33. Europe Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Dry Powder Inhalation Excipients Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Dry Powder Inhalation Excipients Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Dry Powder Inhalation Excipients Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Dry Powder Inhalation Excipients Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Dry Powder Inhalation Excipients Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Dry Powder Inhalation Excipients Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Dry Powder Inhalation Excipients Sales by Country (Tons), 2021–2026
 Table 42. Latin America Dry Powder Inhalation Excipients Sales by Country (Tons), 2027–2032
 Table 43. Latin America Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Dry Powder Inhalation Excipients Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Dry Powder Inhalation Excipients Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Dry Powder Inhalation Excipients Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Dry Powder Inhalation Excipients Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Dry Powder Inhalation Excipients Sales (Tons) by Type (2021–2026)
 Table 51. Global Dry Powder Inhalation Excipients Sales (Tons) by Type (2027–2032)
 Table 52. Global Dry Powder Inhalation Excipients Sales Market Share by Type (2021–2026)
 Table 53. Global Dry Powder Inhalation Excipients Sales Market Share by Type (2027–2032)
 Table 54. Global Dry Powder Inhalation Excipients Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Dry Powder Inhalation Excipients Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Dry Powder Inhalation Excipients Revenue Market Share by Type (2021–2026)
 Table 57. Global Dry Powder Inhalation Excipients Revenue Market Share by Type (2027–2032)
 Table 58. Global Dry Powder Inhalation Excipients Price (US$/Ton) by Type (2021–2026)
 Table 59. Global Dry Powder Inhalation Excipients Price (US$/Ton) by Type (2027–2032)
 Table 60. Global Dry Powder Inhalation Excipients Sales (Tons) by Application (2021–2026)
 Table 61. Global Dry Powder Inhalation Excipients Sales (Tons) by Application (2027–2032)
 Table 62. Global Dry Powder Inhalation Excipients Sales Market Share by Application (2021–2026)
 Table 63. Global Dry Powder Inhalation Excipients Sales Market Share by Application (2027–2032)
 Table 64. Global Dry Powder Inhalation Excipients Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Dry Powder Inhalation Excipients Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Dry Powder Inhalation Excipients Revenue Market Share by Application (2021–2026)
 Table 67. Global Dry Powder Inhalation Excipients Revenue Market Share by Application (2027–2032)
 Table 68. Global Dry Powder Inhalation Excipients Price (US$/Ton) by Application (2021–2026)
 Table 69. Global Dry Powder Inhalation Excipients Price (US$/Ton) by Application (2027–2032)
 Table 70. Protheragen-ING Company Information
 Table 71. Protheragen-ING Description and Business Overview
 Table 72. Protheragen-ING Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 73. Protheragen-ING Dry Powder Inhalation Excipients Product
 Table 74. Protheragen-ING Recent Developments/Updates
 Table 75. DFE Pharma Company Information
 Table 76. DFE Pharma Description and Business Overview
 Table 77. DFE Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 78. DFE Pharma Dry Powder Inhalation Excipients Product
 Table 79. DFE Pharma Recent Developments/Updates
 Table 80. Meggle-Pharma Company Information
 Table 81. Meggle-Pharma Description and Business Overview
 Table 82. Meggle-Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 83. Meggle-Pharma Dry Powder Inhalation Excipients Product
 Table 84. Meggle-Pharma Recent Developments/Updates
 Table 85. Pfanstiehl Company Information
 Table 86. Pfanstiehl Description and Business Overview
 Table 87. Pfanstiehl Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 88. Pfanstiehl Dry Powder Inhalation Excipients Product
 Table 89. Pfanstiehl Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 93. Merck Dry Powder Inhalation Excipients Product
 Table 94. Merck Recent Developments/Updates
 Table 95. Sheffield (Kerry) Company Information
 Table 96. Sheffield (Kerry) Description and Business Overview
 Table 97. Sheffield (Kerry) Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 98. Sheffield (Kerry) Dry Powder Inhalation Excipients Product
 Table 99. Sheffield (Kerry) Recent Developments/Updates
 Table 100. Armor Pharma Company Information
 Table 101. Armor Pharma Description and Business Overview
 Table 102. Armor Pharma Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 103. Armor Pharma Dry Powder Inhalation Excipients Product
 Table 104. Armor Pharma Recent Developments/Updates
 Table 105. Abbott Company Information
 Table 106. Abbott Description and Business Overview
 Table 107. Abbott Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 108. Abbott Dry Powder Inhalation Excipients Product
 Table 109. Abbott Recent Developments/Updates
 Table 110. Norvatis Company Information
 Table 111. Norvatis Description and Business Overview
 Table 112. Norvatis Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 113. Norvatis Dry Powder Inhalation Excipients Product
 Table 114. Norvatis Recent Developments/Updates
 Table 115. Bayer Company Information
 Table 116. Bayer Description and Business Overview
 Table 117. Bayer Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 118. Bayer Dry Powder Inhalation Excipients Product
 Table 119. Bayer Recent Developments/Updates
 Table 120. Jiangsu Daoning Drug Company Information
 Table 121. Jiangsu Daoning Drug Description and Business Overview
 Table 122. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 123. Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product
 Table 124. Jiangsu Daoning Drug Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Dry Powder Inhalation Excipients Distributors List
 Table 128. Dry Powder Inhalation Excipients Customers List
 Table 129. Dry Powder Inhalation Excipients Market Trends
 Table 130. Dry Powder Inhalation Excipients Market Drivers
 Table 131. Dry Powder Inhalation Excipients Market Challenges
 Table 132. Dry Powder Inhalation Excipients Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dry Powder Inhalation Excipients
 Figure 2. Global Dry Powder Inhalation Excipients Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Dry Powder Inhalation Excipients Market Share by Type: 2025 & 2032
 Figure 4. Lactose Product Picture
 Figure 5. Magnesium Stearate Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Dry Powder Inhalation Excipients Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Dry Powder Inhalation Excipients Market Share by Application: 2025 & 2032
 Figure 9. DPI
 Figure 10. MDI
 Figure 11. Nebulizer
 Figure 12. Others
 Figure 13. Global Dry Powder Inhalation Excipients Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Dry Powder Inhalation Excipients Market Size (US$ Million), 2021–2032
 Figure 15. Global Dry Powder Inhalation Excipients Sales (Tons), 2021–2032
 Figure 16. Global Dry Powder Inhalation Excipients Average Price (US$/Ton), 2021–2032
 Figure 17. Dry Powder Inhalation Excipients Report Years Considered
 Figure 18. Dry Powder Inhalation Excipients Sales Share by Manufacturers in 2025
 Figure 19. Global Dry Powder Inhalation Excipients Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Dry Powder Inhalation Excipients Players: Market Share by Revenue in Dry Powder Inhalation Excipients in 2025
 Figure 21. Dry Powder Inhalation Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Dry Powder Inhalation Excipients Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Dry Powder Inhalation Excipients Sales Market Share by Country (2021–2032)
 Figure 24. North America Dry Powder Inhalation Excipients Revenue Market Share by Country (2021–2032)
 Figure 25. United States Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Dry Powder Inhalation Excipients Sales Market Share by Country (2021–2032)
 Figure 28. Europe Dry Powder Inhalation Excipients Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Dry Powder Inhalation Excipients Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Dry Powder Inhalation Excipients Revenue Market Share by Region (2021–2032)
 Figure 36. China Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Dry Powder Inhalation Excipients Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Dry Powder Inhalation Excipients Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Dry Powder Inhalation Excipients Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Dry Powder Inhalation Excipients Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Dry Powder Inhalation Excipients Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Dry Powder Inhalation Excipients by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Dry Powder Inhalation Excipients by Type (2021–2032)
 Figure 56. Global Dry Powder Inhalation Excipients Price (US$/Ton) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Dry Powder Inhalation Excipients by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Dry Powder Inhalation Excipients by Application (2021–2032)
 Figure 59. Global Dry Powder Inhalation Excipients Price (US$/Ton) by Application (2021–2032)
 Figure 60. Dry Powder Inhalation Excipients Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India